论文部分内容阅读
全国人大代表、天津天士力集团总裁闫希军接受记者访谈时表示,避免药品质量问题需要企业责任感和监管体系双管齐下。
Yan Xijun, NPC deputy and president of Tianjin Tasly Group, said when interviewed by reporters: To avoid the problem of drug quality, we need a two-pronged approach to corporate responsibility and regulatory system.